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Metabolism of parathyroid hormone in isolated perfused rat
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Metabolism of parathyroid hormone in isolated perfused rat kidney and
liver combined. Metabolism of synthetic, intact, human parathyroid
hormone (PTH) l0 54 was studied in a new experimental model using
the isolated perfused rat kidney and liver combined. The combined
organs cleared intact PTH significantly faster than the single kidneys (P
< 0.02) or livers (P < 0.02), but not faster than the sum of the
clearances in the single organs. The kidneys cleared intact PTH without
accumulation of NH2-terminal, mid-molecule or COOH-terminal iPTH,
and high-performance liquid chromatography (HPLC) studies did not
reveal any PTH fragments. The livers cleared mid-molecule and
COOH-terminal iPTH significantly slower (P < 0.002) than intact PTH,
and HPLC demonstrated generation of mid-molecule and COOH-
terminal PTH fragments. The combined organs accumulated signifi-
cantly less mid-molecule (P < 0.001) and COOH-terminal (P < 0.03)
iPTH than the single livers, and HPLC demonstrated mid-molecule
peaks that were smaller but not qualitatively different. In conclusion,
the predominance of COOH-terminal PTH fragments in plasma may be
maintained by differential clearance mainly in the liver, excessive
accumulation being prevented by filtration in the kidneys.
Metabolism of intact parathyroid hormone (PTH) has at-
tracted much interest since fragments with high biological
activity may be generated in this process [1, 2] and fragments of
PTH may act as uremic toxins [2, 3]. PTH fragments are
generated and secreted by the parathyroid glands [4—6], but
under normal conditions the peripheral metabolism of secreted
intact PTH may be the main source of PTH fragments in plasma
[5, 7].
A widely accepted model of the peripheral metabolism of
PTH was proposed by Martin et a! [8] based on several animal
studies in vivo and vitro (Martin et al [9, 10], Hruska et al [11,
12]). According to this theory, intact PTH is cleaved by the liver
into equal amounts of NH2-terminal and COOH-terminal frag-
ments that are not further metabolized by the liver. The much
lower concentrations of NH2-terminal than of COOH-terminal
fragments normally found in the circulation were explained by
further peritubular extraction and filtration of NH2-terminal
fragments in the kidneys and by extraction of NH2-terminal
fragments by bone, in contrast to COOH-terminal fragments
only being cleared by filtration in the kidneys. Thus, in this
model the end-product of the metabolism of intact PTH in the
liver would be the substrate for further degradation in the
kidney, and the two organs might exert a synergistic effect on
each other in the metabolism of intact PTH. Studies examining
only the influence of one organ, especially the relatively few
investigations to date of the metabolism of intact PTH in the
isolated perfused liver [13, 141 or kidney [10, 12, 14, 15], were
not designed to elucidate the effects of possible interaction
between the two organs.
We therefore developed a new experimental model [161,
combining the isolated perfused rat kidney and rat liver (Fig. 1).
This model permitted a comparison of the metabolism of added
synthetic intact PTH in the combined organs with the metabo-
lism in the single organs under identical conditions. Clearances
were measured by an assay specific for intact PTH. Generation
of PTH fragments in the perfusion models was investigated by
high-performance liquid chromatography (HPLC) and assays
highly specific for NH2-terminal, mid-molecule, or COOH-
terminal iPTH. The combined kidney and liver compared with
the single perfused liver proved to be an interesting model of a
fundamental aspect of uremia, that is, the absence of a func-
tioning kidney. Thus, this model may be used to explain the
pattern of NH2- and COOH-terminal iPTH plasma levels seen
in renal failure.
Methods
Sources of PTH and PTH fragments
Synthetic human parathyroid hormone were: synhPTH-(1-
84)[Asp76] (synthesized at the Peptide Institute, the Protein
Research Foundation, Minoh, Osaka, Japan); synhPTH-(39-
68), synhPTH-(39-84), synhPTH-(53-84), and synhPTH-(69-84)
were obtained from Peninsula Laboratories (Belmont, Califor-
nia, USA). SynhPTH-(13-34), synhPTH-(1-34), synhPTll-(1-
44), synhPTH-(28-48), synhPTH-(44-68), and synhPTH-(64-84)
were obtained from Bachem (Bubendorf, Switzerland). Highly
purified intact bovine parathyroid hormone was a gift from
Jerry Morrissey, Ph.D., Renal Division, Washington University
(St. Louis, Missouri, USA).
Radioimmunoassays (RIAs) for intact PTH and PTH
fragments
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1-84 RIA, (N-Tact PTH, Immuno Nuclear, Stiliwater, Min-
nesota, USA). Samples were extracted and concentrated on
columns containing chicken anti-hPTH-(1-34) antibody coupled
to Sepharose beads. After washing, column eluates were mea-
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Fig. 1. Schematic outline of the system for
2 2 combined kidney and liver perfusion. (Figure
reprinted with permission from Eur J Physiol
409:220—222, 1987). A, Perfusate reservoir
with stirrer; B, Roller pumps; C, 8 m filters;
D, Silastic lungs; E, Bubble traps; F, Pressure
transducer; G, Vial for urine collection; H,
Kidney chamber; I, Manometer connected to
portal vein catheter; J, Caval catheter with
sampling port; K, Bile catheter and syringe
_________
for bile collection. Samples for disappearance
curves were drawn from the central reservoir.
sured in a RIA using a chicken antibody binding only hPTH-
(43-68).
1-34 RIA, (INS-PTH, Nichols Institute, San Juan Capist-
rano, California, USA). This RIA used a chicken antibody
raised against synhPTH-(1-34) and specific for the NH2-ter-
minal part of the PTH molecule.
53-68 RIA, (PTH OMEGA, Cambridge Medical Diagnostics,
Cambridge, Massachusetts, USA). This RIA used a goat anti-
serum specific for the hPTH-(53-68) sequence.
53-84 RIA, (MILAB, Malmö Immunlaboratorium AB,
Malmö, Sweden). This assay used a chicken antibody highly
specific for the COOH-terminal part of the PTH molecule.
The performance of these assays has been validated in our
laboratory before [14], including dilution series to test parallel-
ism against synhPTH-(1-84) in perfusion medium. The 1-84 RIA
was found to be specific for intact PTH, the 1-34 RIA was
specific for the NH2-terminal region, the 53-68 RIA was specific
for the mid-molecule region, and the 53-84 RIA was specific for
the COOH-terminal region of PTH (Fig. 2).
Medium for organ perfusions
All experiments were performed with modified Krebs-Hense-
leit bicarbonate buffer containing 5 m glucose, 67 glliter
bovine serum albumin (fraction V, Miles Laboratories, Elkhart,
Indiana, USA) and all 20 physiological L-amino acids, Electro-
lyte composition was (in mM) 141 Na, 5 K, 3 Ca, 0.7 Mg, 0.7
SO4, 25 HCO3, 122 Cl, 3 P04, and 4 lactate.
Kidney perfusion technique
Experiments were performed on male Wistar rats maintained
on a standard pellet diet and allowed water ad libitum. The
animals were anesthetized with 2.5% Thiopental sodium 1.6 to
2.2 ml intraperitoneally. The right kidney was cannulated with
a 19-gauge blunted needle via the superior mesenteric artery
without interruption of flow as described before [16].
Liver perfusion technique
Female Wistar rats were fasted 24 hours before the experi-
ments but allowed free access to water. Pentobarbital sodium
anesthesia, 6 mg per 100 g rat body weight, was given intraper-
itoneally. The bile duct was cannulated with PE-50 tubing for
bile collection. The portal vein and the inferior caval vein were
cannulated with 14 G catheters and perfusion was conducted as
described before [161.
Combined perfusions
These experiments were performed by two operators, per-
mitting the two organs (one from each rat) to be cannulated at
the same time. After an equilibration period of 30 minutes, the
isolated perfused kidney and the isolated perfused liver con-
tained within the same thermostatically-controlled plexiglass
chamber were juxtaposed to share the same beaker with recir-
culating perfusate (Fig. 1). A detailed technical description of
the perfusion circuit for combined perfusions has been pub-
lished before [16]. Priming volume in the combined circuit was
only 80 ml.
HPLC
Reverse-phase HPLC was performed using a water/acetoni-
trile/trifluoroacetic acid (TFA) solvent system, and Waters
NOVA-PAK C18 RadialPak 4 i columns 0.8 x 10 cm com-
pressed in a Z-MODULE (Waters Associates, Rochester, Min-
nesota, USA), and operated at ambient temperature. The two
limit solvents, 0.1% TFA (TFA, CF3 COOR) in water and 50%
acetonitrile in 0.1% TFA, were mixed by two pumps in propor-
tions determined by a Waters 721 System Controller. The
gradient used in all separations is shown in Figure 3. Flowrate
was 1 mi/mm.
The elution positions of various PTH fragments was estab-
lished by injecting 5 to 20 g quantities of the different frag-
ments dissolved in 200 1td 0.1% TFA into the system and
measuring ultraviolet absorption of column eluates at 215 nm
(Fig. 3). Perfusate samples (6 ml each) were extracted on three
C18 Sep-Paks before HPLC. Priming and rinsing procedures for
the Sep-Paks were as described by Bennett, Solomon and
Goltzman [171. Lyophilized Sep-Pak eluates were redissolved
in 300 d 0.1% TFA, 200 pJ of which were injected on the HPLC
column. Column eluates were collected in 1 ml fractions,
lyophilized, redissoived in 1 ml of pentobarbital sodium buffer
with EDTA and human serum proteins, and analyzed in the
I I
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Fig. 2. Disappearance of immunoreactive parathyroid hormone
(iPTH) from the perfusates of (A) 5 isolated kidneys, (II) 6 isolated
livers, and (C) 6 kidneys and livers combined. Synthetic human PTH-
(1-84) was added at 1,000 pmol/liter at time 0. iPTH was measured in
four assays: (D) 1-84 RIA; () 1-34 RIA; (0) 53-68 RIA; (•) 53-84 RIA.
Measured values corrected for sampling are expressed as percent of
estimated initial values. Results are means SE. Liver: Significantly
different from iPTH (% of initial reactivity) measured in 1-84 radioim-
munoassay (RIA) at same time: *P < 0.05; ** < 0.01; *** < 0.001.
Kidney and liver combined: Significantly different from iPTH (% of
initial reactivity) measured in 1-84 RIA at same time: *D < 0.05.
PTH assays. Recovery of 10 to 1,000 pmol/liter of different
NH2- and COOH-terminal synhPTH fragments in perfusate was
also tested in this system.
Experimental design
Organ perfusions. The circulating volume was 200 ml in all
experiments to allow sampling for all assays and HPLC sepa-
rations. The initial stabilizing and control period was fifty
minutes for both kidneys, livers, and combined perfusions.
Perfusate was sampled 5, 15, 30, 60, and 90 minutes after the
addition of PTH, and analyzed in four PTH assays. The results
were corrected for sampling and plotted versus time on a
semilogarithmic scale. The clearances were calculated from the
regression lines for each assay.
To be able to measure the production of fragments with
HPLC and the different assays, synhPTH-(1-84) was added to
the perfusates at an initial concentration of 1000 pmolll (5
kidneys, 6 livers, and 6 combined perfusions).
Furthermore, 25 control perfusions were conducted under
various other experimental conditions. These are summarized
in Table 4, and described in the Results section.
The five single kidneys and the six single livers used as
controls for the six combined perfusiops in this study (Table 3)
were selected among twenty single kidneys and eighteen single
livers perfused the same way in our laboratory. The results
obtained with the remaining fifteen kidneys and twelve livers
were not significantly different from the results shown in Table
3. However, only the perfusions presented were conducted
during the same period of time as the combined perfusions and
alternating with these, using the same stocks of buffers and
BSA as the combined perfusions. This selection implied, that
results obtained with four of the single kidneys and four of the
single livers presented here have been used as part of a material
presented before [14].
HPLC studies
Perfusate samples from five kidney perfusions, six liver
perfusions, and six combined perfusions were analyzed by
HPLC. Samples drawn 60 or 90 minutes after the addition of
synhPTH-(1-84) at 1000 pmol/liter were fractionated by HPLC
and analyzed in the PTH assays specific for NH2-terminal,
mid-molecule and COOH-terminal IPTH, respectively.
Data and statistical analysis
The data are given as means sr where nothing else is
stated. Parametric linear regression, and Student's I-test for
paired or unpaired samples, as appropriate, were used. The
value of Student's t in the comparisons between the sum of the
clearances in the single kidneys (K) plus livers (L) versus the
clearances in the combined organs (C) was calculated by the
formula: t = (MeanK + MeanL — MeanC)/\/(sEMK2 + SEML2 —
sEMc2). All significance limits are two-sided.
Results
Function of the perfused kidneys
Results from the kidney perfusions with synhPTH-(1-84)
added at an initial concentration of 1 . i09 M are given in Table
1. No significant differences were found between the single
kidneys and the kidneys together with livers, when the func-
tional parameters were determined as averages of the whole
experimental period of 90 minutes for each kidney. When each
urine sampling period of 30 minutes was analyzed separately,
Ca excretion was found to be significantly (P < 0.05) lower in
the single kidneys, 42 30 nmol . min' . g', than in the
kidneys combined with livers, 96 39 nmol . min . g,
during the last 30 minutes of the experimental period. Ultrafil-
S..
C Kidney and liver combined
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Kidney
Kidney
alone
combined
with liver
Number of perfusions 5 6
Kidney weight, g 1.36 0.07 1.37 0.05
Perfusion pressure, mm Hg 99 2 89 10
Perfusate flow, ml min' . g' 28 3 31 6
Urine production, 41 12 55 27d min' . g'
p-Aminohippuric acid clearance, 5.9 1.2 5.1 1.8
ml. min' .g'
Inulin clearance, id. min' .g' 602 145 495 166
Filtration fraction, % 2.2 0.3 1.6 0.6
Na excretion, mo!. min' .g' 3.2 1,8 5.4 3.0
Fractional reabsorption of Na, %
K excretion, i.&mol. min' . g' 96.1 2.31.6 0.7 92.4 4.41.8 0.6
Fractional excretion of K, % 59 13 74 21
Ca excretion, nmol. min' .g' 40 28 81 39
Fractional excretion of Ca, % 5.4 3.2 10.9 6.8
Pi excretion, nmol. min' . g' 154 83 180 92
Fractional excretion of Pi, % 10.7 5.0 14.8 7.8
Values are means SD based on averages for each kidney of results
obtained during the whole experimental period with synhPTH-(1-84)
l0— at. This was 50 to 140 minutes after cannulation. None of the
differences between the two groups are significant.
Fig. 3. High-performance liquid
chromatography (HPLC) separation of
synthetic human parathyroid hormone (PTH)
< fragments. Between 10 and 20 sg of each
peptide was chromatographed. Elution
positions were determined by separate
0 chromatograms of each fragment preceding
the chromatogram shown. Amino acid
sequences of the fragments are indicated; Ul
and U2 were unspecific impurities of the
fragments. Ultraviolet absorption was
measured at 215 nm. Acetonitrile/0. 1%
trifluoroacetic acid gradient used in all
separations is shown.
Liver
Liver
alone
combined
with kidney
Number of perfusions 6 6
Rat weight, g 208 20 196 14
Liver wet weight, g 6.58 0.53 7.31 1.11
Portal vein pressure, 8 3 11 3
cm Ff20
Bile flow, j.d. hour' 140 59 200 83
Oxygen consumption, 18.12 2.95 16.12 2.23
02 smol min'
02 pmol. min' g' 2.79 0.66 2.27 0.60
Perfusate flow (fixed), 35 35
ml min'
Values are means SD based on averages for each liver of results
obtained during the whole experimental period with synhPTH-(l-84)
iO 54. This was 50 to 140 minutes after cannulation. None of the
differences between the two groups are significant.
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Table 1. Function of perfused rat kidney Table 2. Function of perfused rat liver
terable calcium was assumed to be 56% of total calcium in the
calculations [181. None of the other functional parameters
exhibited significant differences between single kidneys and
combined kidneys and livers at any time.
Function of the perfused livers
No significant differences were found at any time during the
experimental period between the functional parameters of the
single livers and of the livers combined with kidneys (Table 2).
Clearance of PTH-(1-84) in the perfusion models
Results from the perfusions with synhPTH-(l-84) added at an
initial concentration of 1 . l0M to five kidneys, six livers, and
six kidneys and livers combined are shown in Figure 2.
In the kidneys, the disappearance of intact iPTH, and of
NH2-terminal, mid-molecule and COOH-terminal iPTH was
parallel. In the livers, the disappearance of mid-molecule and
COOH-terminal iPTH was significantly (Fig. 2) slower than the
disappearance of NH2-terminal and intact iPTH, the two latter
disappearing in a parallel fashion. In the kidney and the liver
combined, the disappearance of intact iPTH and NH2-terminal
iPTH was not significantly different. Accumulation of mid-
molecule iPTH was not significant (P 0.08 at 60 mm, P 0.13
at 90 mm) either, whereas COOH-terminal iPTH disappeared
significantly (Fig. 2) slower than intact iPTH. From these data
it was also found that at ninety minutes, significantly less
mid-molecule iPTH (P < 0.001) and COOH-terminal iPTH (P <
0.03) was present in the perfusates of the combined perfusions
than in the perfusates of the single livers.
The metabolic clearances calculated from the disappearance
curves are given in Table 3.
No significant differences were found between the clearance
of intact PTH and the clearances of NH2-terminal, mid-mole-
cule, or COOH-terminal iPTH in the kidneys. Also, the clear-
ance of intact PTH was not significantly different from the
clearance of inulin (P 0.48).
The delayed disappearance of mid-molecule and of COOH-
terminal iPTH in the liver, and of COOH-terminal iPTH in the
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Table 3. Clearance of synhPTH-(l-84) i0 M in perfused rat organs
measured in four radioimmunoassays
Kidney and
Kidney Liver liver together;N5 N6 N=6
Assay id min' P
1-84 RIA 787 230 870 126 1204 226 <0.005
l-34R1A 781 174 871 122 1011 200 <0.001
53-68 RIA 816 337 522 130" 970 75 <0.05
53-84 RIA 650 269 529 l46 835 l88C <0.05
Inulin 660 115 — 382 152 <0.01
Values are means SD.
Significantly different from 1-84 clearance in the liver:
ap <0.002, "P < o.ooi.
Significantly different from 1-84 clearance in the combined organs:
P < 0.02.
P-values in right column relate to the sum of the clearances in the
single kidneys and the single livers, compared with the clearances in the
combined organs.
combined organs, was reflected in clearances that were signif-
icantly lower than the clearances of intact iPTH in these
perfusion models.
The kidney and the liver combined cleared intact IPTH
significantly faster than the single kidneys (P < 0.02) or the
single livers (P < 0.02), but the clearances of PTH in the
combined model was significantly (Table 3, right column) lower
than the tentative sum of the clearances obtained with the single
organs.
Results from twenty-five control perfusions are summarized
in Table 4.
SynhPTH-(l-84) added at 5. i0 M to one kidney, one liver,
and one combined perfusion resulted in clearances within the
same ranges as in the experiments with synhPTfl-(l-84) 1 . l0
M, as did synhPTH-(l-84) added at 2. 10° M to one kidney,
one liver, and one combined perfusion. These perfusions were
performed to further substantiate that the metabolic clearance
rates could be calculated assuming first order kinetics.
Highly-purified intact bovine PTH added at 1 . iO M to one
kidney, one liver, and one combined perfusion gave similar
results. These perfusions were performed to facilitate compar-
ison with earlier studies, and to test the influence of the PTH
preparation used.
To test that the additive characteristic of the clearance
concept held true in the perfusion model, one perfusion was
conducted with two kidneys combined. Fractional excretion
C,H/C,flUIjfl in this model was 0.9, same as in the single
kidneys. Thus the system accurately reflected the presence of
two filtering kidneys. One perfusion was conducted with two
livers combined, The oxygen consumption in this model was 14
mol. min' + 15 mol. min'.
One kidney was perfused for 60 minutes, the perfusate was
then transferred to a liver that was perfused for 90 minutes. A
similar perfusion was conducted with transfer of perfusate from
liver to kidney. The clearances in these models were of the
same order as in the corresponding single organs.
One kidney perfusion, two liver perfusions, and one com-
bined perfusion were performed with removal of the organs
after 30 to 45 minutes and continued sampling for 60 minutes.
After removal of the organs, the clearance of iPTH was
indistinguishable from zero. The clearances were also zero in
two control experiments without any organs in the perfusion
circuit.
HPLC studies
The capability of the HPLC system used to separate various
NH2-terminal and COOH-terminal synhPTH fragments is dem-
onstrated in Figure 3. Even 20 pg synhPTH-(l-84) could not be
visualized at 215 nm, but by fractionation and assaying of
column eluates as described it was shown to elute four minutes
later than synhPTH-(l-34). Using this system, 100 pmol/liter of
synhPTH-(l-34), synhPTH-(l3-34) and synhPTH-(l-44) in per-
fusate could be distinguished from synhPTH-(l-84) 1000 pmoll
liter.
Perfusate samples from three kidneys, four livers and four
combined perfusions drawn at 60 minutes were analyzed by
HPLC as described in the legend to Figure 4.
In the kidney perfusate only one peak was found, reacting in
the NH2-terminal, the mid-molecule, and the COOH-terminal
RIA. This peak, representing the remaining synhPTH-(l-84),
served as internal standard in all separations. Thus no NH2-
terminal or mid-molecule/COOH-terminal PTH fragments were
demonstrated. The chromatographic pattern was the same in all
three kidney perfusions analyzed.
In the liver perfusate, only the intact PTH peak was found in
the NH2-terminal RIA. In the mid-molecule RIA one more
broad peak was detected eluting near the established elution
positions of various mid-molecule/COOH-terminal synhPTH
fragments. Some fractions within this peak also reacted in the
COOH-terminal RIA. The chromatographic pattern was the
same in all four liver perfusions analyzed.
In the perfusate from kidney and liver combined, no NH2-
terminal fragments were found either. Besides the slim intact
PTH peak a broad peak was found in the mid-molecule assay,
eluting in the same fractions as the mid-molecule peak found in
the livers, but somewhat smaller. This peak was not found in
the COOH-terminal RIA, but as seen from Figure 4 comparing
with the liver it might have disappeared just below the detection
limit. The chromatographic pattern was the same in all four
combined perfusions analyzed except that in one case the
mid-molecule peak was not found. Samples drawn at 90 minutes
from two liver perfusions and two combined perfusions were
also separated on HPLC. Fractions were only analyzed in the
mid-molecule RIA, permitting lower dilution. These studies
demonstrated that both in the livers and in the combined
perfusions the broad mid-molecule!COOH-terminal peak con-
sisted of several, poorly defined peaks without any consistent
pattern.
Discussion
Previous studies from our laboratory have dealt with the
metabolism of synthetic human, intact parathyroid hormone
[synhPTH-( 1-84)] in single isolated perfused rat kidneys and
livers [14]. The advantages of the use of isolated perfused
organs and the limitations imposed by these models and the use
of higher than physiologic levels of PTH have been discussed in
detail before [14]. It should also be noted, that the conditions in
vivo develop during a steady state situation measured over days
and weeks, whereas the results of the present investigation
were obtained over a short and limited period of perfusion.
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Table 4. Summary of 25 control perfusions
Perfusion model
Number of
perfusions PTH added
Clearance, d. min'
Intact PTH (1-84) Inulin
Single kidney I synhPTH-(l-84) 5000 pmol/liter 643 1032
Single liver I synhPTH-(l-84) 5000 pmol/liter 700
Kidney and liver combined I synhPTH-(l-84) 5000 pmol/liter 1142 791
Single kidney I synhPTH-(1-84) 200 pmol/liter 548 809
Single liver I synhPTH-(l-84) 200 pmollliter 629
Kidney and liver combined I synhPTH-(1-84) 200 pmol/liter 899 478
Single kidney I bPTH-(1-84) 1000 pmol/liter 261 353
Single liver I bPTH-(I-84) 1000 pmollliter 684
Kidney and liver combined I bPTH-(I-84) 1000 pmollliter 1398 899
Two kidneys combined I synhPTH-(1-84) 1000 pmollliter 843 923
Two livers combined I synhPTH-(l-84) 1000 pmollliter 1284
Sequential perfusion: Single kidney 1 synhPTH-(1-84) 1000 pmollliter 878 971
Sequential perfusion: Single liver 1 Perfusate transferred from kidney 564
Sequential perfusion: Single liver I synhPTH-(1-84) 1000 pmol/liter 508
Sequential perfusion: Single kidney 1 Perfusate transferred from liver 567 462
Single kidney I synhPTH-(l-84) 1000 pmol/liter 603 963
After removal of the kidney I Same perfusate as above a a
Single liver 2 synhPTH-(l-84) 1000 pmol/liter 1209
After removal of the liver 2 Same perfusate as above a
Kidney and liver combined I synhPTH-(I-84) 1000 pmollliter 1646 1068
After removal of the kidney and liver 1 Same perfusate as above a a
Perfusion circuit without organs 2 synhPTH-(l-84) 1000 pmol/liter a a
a No significant correlation between time and the disappearance of PTH or inulin as indicated, that is, no clearance, even if calculated values
were slightly positive or negative. Where two perfusions were performed, the results given are averages of the two perfusions.
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Fig. 4. High-performance liquid chromatography separation (HPLC) of one perfusate sample from one isolated perfused kidney (A), one sample
from one liver (B), and one sample from one combined perfusion (C). The samples were taken 60 minutes after addition of synthetic human
parathyroid hormone [synhPTH-(1-84)J at 1,000 pmol/liter to perfusate. After lyophilization, the 70 collected fractions were redissolved in assay
buffer. Different further dilutions were needed for each of the three PTH assays. Curves are actual assay results not multiplied by dilution factors.
Dashed lines indicate sensitivity limits of the different radioimmunoassays (RIAs).
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The anticalciuric response to the added synhPTH-(1-84)
found in the single kidneys was abolished during the perfusions
where the liver was also present. Thus in the combined perfu-
sions the calcium excretion became of the same order as in
single kidneys without PTH added [14]. The disappearance of
intact PTH was significantly faster in the combined perfusions
than in the single kidneys (P < 0.02), but as much as 149 42
pmollliter synhPTH-(l-84) was measured in the intact PTH RIA
at 90 minutes in the combined perfusions, and this concentra-
tion might still have been expected to exert biological activity.
However, Keutmann et al [19] found that human PTH-(1-34)
was about ten times less potent than rat PTH-(l-34) in the rat
adenylate cyclase assay, so in terms of bioactivity the present
investigation may have been performed at near-normal physio-
logical PTH concentrations.
The 1-84 RIA used in the present investigation has previously
been shown by our laboratory to be specific for intact PTH [141.
Thus, this assay accurately reflected the disappearance of the
added synhPTH-(l-84) unaffected by any PTH fragments that
might have been generated.
Glomerular filtration rate (GFR), determined as the disap-
pearance of inulin from the perfusates, was significantly (P <
0.01) lower in the kidneys combined with livers than in the
single kidneys (Table 3). We have found the same significant
difference in a perfusion series without PTH added [16]. A
possible explanation is generation of vasoactive substances by
the combined kidney and liver. Thus, we have been able to
measure production of angiotensin I by the combined organs,
whereas the single organs did not produce measurable amounts
of this precursor of angiotensin II.
The combined organs cleared intact PTH significantly faster
than the single kidneys (P < 0.02) or livers (P < 0.02). but the
clearance in the combined model was significantly (Table 3,
right column) lower than the tentative sum of the clearances
obtained with the single organs. However, we have previously
shown that synhPTH-(l-84) is mainly removed by filtration in
the isolated perfused rat kidney with a glomerular sieving
coefficient of at least 0.8 [14]. Therefore, it would be appropri-
ate to correct for the higher inulin clearances found in the single
kidneys in this study. Inulin clearances in combined and single
kidneys respectively, calculated from the disappearance of
inulin from the perfusates the same way as intact PTH clear-
ances were calculated, differed more than the inulin clearances
calculated from urine excretions. While the latter method may
be best suited for the calculations of fractional electrolyte
handling by the kidney, it may not be a precise measure of GFR
over longer periods of time, as has been discussed in detail by
Maack [20]. The sum of the intact PTH clearances in the single
livers and kidneys, corrected for GFR, was 1302 1d min,
versus 1204 d . min' in the combined organs, not significantly
different (P 0.78). Thus, no synergistic effect was attained by
combining the organs. As discussed in the introduction such an
effect might have been expected if the liver selectively took up
intact PTH, as proposed by Martin et at [8—10].
Although the NH2-terminal RIA, the mid-molecule RIA, and
the COOH-terminal RIA used were specific for the respective
main regions of the PTH molecule, they reacted with all
fragments containing the necessary antigenic sequence, and
immunoreactivity of small PTH fragments was unpredictable
[14]. So, in contrast to the intact PTH RIA, no simple stoichio-
metric relationship could be assumed between the amounts of
fragments present in the perfusate and immunoreactivity mea-
sured in these assays. However, they were all calibrated against
synhPTH-( 1-84), so if the added synhPTH-( 1-84) disappeared
without release of any fragments back to the perfusates, then
the disappearance curves measured with these assays should be
parallel with the intact PTH disappearance curve. This was the
case in the kidney perfusions (Fig. 2), and the HPLC studies
(Fig. 4) confirmed that no detectable fragments were produced
by the kidneys. Conversely, the livers released mid-molecule
and COOH-terminal PTH fragments to the perfusate as dem-
onstrated by the HPLC studies, and this accumulation of
immunoreactive fragments of the added intact PTH was re-
flected in the significant distance between the intact PTH
disappearance curve and the mid-molecule and COOH-terminal
disappearance curves. The combined organs accumulated sig-
nificantly less mid-molecule (P < 0.001) and COOH-terminal (P
< 0.03) iPTH than the single livers. Mid-molecule PTH frag-
ments could still be measured in the HPLC studies, and they
exhibited the same pattern of several mid-molecule/COOH-
terminal subfractions as found in the single liver perfusions.
The metabolism of intact PTH in the single kidney and liver
has been discussed before [14]. When comparing the results
from the combined organs (Fig. 2) with those obtained with the
single kidney and liver, respectively, it is clear that in this
model the heterogeneity of immunoreactive PTH resulting from
the added intact PTH, including the lower concentrations of
intact and NH,-terminal PTH than of mid-molecule and COOH-
terminal PTH, was due to differential clearance in the liver
rather than in the kidney. Segre et a! [21] and Bringhurst et al
[22] found cleavage of intact bovine PTH by isolated rat Kupifer
cells, fast degradation of the resulting NH2-terminal fragments,
and slow if any degradation of COOH-terminal fragments.
These findings were repeated by Pillai and Zull [23] who
characterized slightly different COOH-terminal fragments and
discussed the limitations of these models using centrifugal
methods or colloidal iron to separate the liver cells. The present
investigation using the intact liver in vitro supports the findings
with isolated Kupffer cells. Studies in vivo by D'Amour et al
[24, 25], and Segre et al [26], and an earlier study by Canterbury
et al [131 with the isolated perfused liver also give evidence for
differential clearance by the liver.
Martin et al [27], and Hruska et al [11] found significant
peritubular uptake of intact and NH2-terminal bovine PTH by
kidneys of rats and dogs in vivo and vitro. However, Kau and
Maack [15] found only filtration of intact bovine PTH in the
isolated perfused rat kidney, and Martin et al [10] concluded
that under normal conditions the kidney mainly removes PTH
by filtration. In the present investigation the kidneys removed
synhPTH-(l-84) at the same rate as inulin, together with various
mid-molecule/COOH-terminal PTH fragments generated by the
isolated perfused rat liver. The kidneys in this study did not
release fragments of the filtered intact PTH back to the perfus-
ate. In the studies by Barling and Christie [28], and Hruska et al
[12] PTH fragments were generated, but at a very variable rate
as some kidneys produced only small amounts of PTH frag-
ments.
The combined perfused kidney and liver compared with the
perfused liver alone (Fig. 2) illustrate one fundamental aspect of
uremia, that is, the absence of a functioning kidney. It is
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suggestive that the PTH profile in the perfusates of the com-
bined organs with intact PTH added ended up looking very
much like the normal situation in vivo with low levels of intact
PTH and NH2-terminal iPTH and higher levels of mid-molecule
and COOH-terminal iPTH. In comparison, the perfusates from
the single livers demonstrated the same alterations as seen in
uremic sera with higher levels of intact PTH and NH2-terminal
iPTH and very high levels of mid-molecule and COOH-terminal
iPTH. If the different levels of NH2-terminal and COOH-
terminal iPTH were maintained by the kidney rather than the
liver as proposed by Martin et al [8], other systems such as bone
or low-capacity processes in serum would have to take over this
function in uremic patients.
The results of the present investigation indicate that the
predominance of COOH-terminal iPTH in plasma may be
maintained by differential clearance of PTH fragments mainly in
the liver, an excessive accumulation being prevented by filtra-
tion in the kidney. In accordance with this, no synergistic effect
was observed by combining the isolated perfused rat kidney and
liver, and the HPLC profile of mid-molecule/COOH-terminal
iPTH in the combined organs was not qualitatively different
from that of the single perfused livers. This model offers a
simple explanation of some of the changes in the peripheral
metabolism of PTH found in uremia.
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